Jeremy Shaver

Jeremy M. Shaver, Ph.D., is an Analytical Chemist and Data Science leader with extensive experience in the biopharmaceutical and chemical industries. Currently, he serves as the Senior Director of Research Data Science for Biotherapeutic Process Sciences at Pfizer in Bothell, WA, a role he has held since December 2023. In this position, Jeremy leads a Data Science group focusing on AI/ML data analytics and modeling, as well as physical laboratory automation for process development. Previously, Jeremy was the Senior Director of Data Science at Seagen (purchased by Pfizer in 2023), where he led data science innovation, data engineering, CMC statistics, and laboratory automation for ADC process development and manufacturing. Other roles he’s held in the biotech industry include: Senior Director of Data Science at Adaptive Biotechnologies, in the T-Cell receptor Antigen Map project (focusing on disease models for diagnostics and large-scale immune system profiling), and Scientific Director of Data Science at Just–Evotec Biologics. At Just-Evotec, he founded the biologics Data Science team and developed early novel in silico generative AI and ML/AI tools for antibody discovery and optimization. He got his start in the AI/ML space as the Chief of Technology Development at Eigenvector Research, where he led many dozens of data science and software development projects on many chemical, pharmaceutical, and other physical-science related programs.